ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
95,632.14
-1.62%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Acorda Therapeutics Inc (ACOR) Cotización

Acorda Therapeutics Inc

Acorda Therapeutics Inc (ACOR)

NASDAQ
0.661
0.00
(0.00%)
Cerrado 22 Diciembre 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
Fuera de horario: -
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
0.661
Postura de Compra
0.565
Postura de Venta
0.5878
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
0.661
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

ACOR Últimas noticias

Más noticias

Acorda Therapeutics Announces Delisting from Nasdaq

Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with...

15 Abril 2024
Business Wire

Acorda Therapeutics Announces Nasdaq Delisting Notification

Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective...

03 Abril 2024
Business Wire

Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement

Acorda Files for Voluntary Chapter 11 Protection to Facilitate Orderly Sale Acorda Enters into a Restructuring Support Agreement with over 90% of the Secured Convertible Noteholders Patient...

01 Abril 2024
Business Wire

Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally scheduled for Monday, April 1 at 4:30...

01 Abril 2024
Business Wire

Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a webcast/conference call in conjunction with its fourth quarter and year end 2023 update and financial results for Monday, April 1 at...

25 Marzo 2024
Business Wire

Form 8-K - Current report

11 Enero 2024
Edgar (US Regulatory)

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced it will regain global commercialization rights to FAMPYRA® (fampridine) following a decision by Biogen to terminate the license and...

11 Enero 2024
Business Wire

Form 8-K - Current report

01 Diciembre 2023
Edgar (US Regulatory)

Form 8-K - Current report

13 Noviembre 2023
Edgar (US Regulatory)

Acorda Therapeutics Reports Third Quarter 2023 Financial Results

INBRIJA® (levodopa inhalation powder) Q3 2023 U.S. net revenue of $8.1 million; 4% increase over Q3 2022 AMPYRA® (dalfampridine) Q3 2023 net revenue of $15.7 million; 26% decrease over Q3 2022...

13 Noviembre 2023
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ACOR - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Acorda Therapeutics?
El precio actual de las acciones de Acorda Therapeutics es US$ 0.661
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Acorda Therapeutics?
Acorda Therapeutics ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

ACOR Discussion

Ver más
Renee Renee 4 meses hace
ACORQ: BK PLAN effective. All shares cancelled.

https://otce.finra.org/otce/dailyList?viewType=Deletions
👍️0
Renee Renee 8 meses hace
ACOR changed to ACORQ, bankruptcy. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
Monksdream Monksdream 8 meses hace
ACOR new 52 week lo

👍️0
J-mak J-mak 8 meses hace
Is this a gap between 10 and 4?
👍️0
Monksdream Monksdream 8 meses hace
ACOR new 52 lo
👍️0
willlbone willlbone 8 meses hace
Squirrel buried this ACORn.
👍️0
Monksdream Monksdream 8 meses hace
ACOR new 52 lo
👍️0
Monksdream Monksdream 8 meses hace
ACOR new 52 lo
👍️0
Monksdream Monksdream 9 meses hace
ACOR new 52 week low
👍️0
Firestorm22 Firestorm22 9 meses hace
Definitely not a good sign
👍️0
Disquisition Disquisition 9 meses hace
HORRENDOUS DUMPING
👍️0
INFINITI INFINITI 2 años hace
Boom time
👍️0
INFINITI INFINITI 2 años hace

On May 10, 2023, Acorda Therapeutics, Inc. (the “Company”) issued a press release announcing that the Company will make a cash interest payment of approximately $6.2 million in satisfaction of the interest payment due on June 1, 2023, as provided for under the indenture governing the Company’s 6.00% Convertible Senior Secured Notes due 2024 (the “Notes”). The Company will make the interest payment using cash that was placed in escrow when the Notes were issued, which is reported on the Company’s balance sheet as restricted cash. The June 1 payment is the last payment in which the Company has the option to pay in cash or shares of its common stock. All future payments will be made in cash. A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
👍️0
INFINITI INFINITI 2 años hace
Looking Good here for a nice bounce $$$$
👍️0
81vette 81vette 2 años hace
ZERO BORROW since 11:30,fee 33%with NO REBATE,tomorrow could be even better run
👍️0
81vette 81vette 2 años hace
Held up insanely well,still .10 over parabolic,great strength for confidence continue tomorrow!! Super pick y’all !!
👍️0
barnyarddog barnyarddog 2 años hace
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China

Mon, May 8, 2023
https://finance.yahoo.com/news/acorda-therapeutics-chance-pharmaceuticals-announce-110000455.html
👍️0
81vette 81vette 2 años hace
ZERO BORROW now,should keep going,we shall see,i am holding until tomorrow no matter what,(have to run errands)
👍️0
INFINITI INFINITI 2 años hace
Nice got some
👍️0
81vette 81vette 2 años hace
loaded up,heading for ZERO BORROW now,running out of shares,only 7k left
👍️0
Mt. Blanc Mt. Blanc 2 años hace
ACOR supporting itself under the buck. In time more will get on board.

mb
👍️0
Mt. Blanc Mt. Blanc 2 años hace
ACOR with very thin trading. Should be trading in the low 1s pretty soon.

Off radar and can move quickly when news hits.

mb
👍️0
Mt. Blanc Mt. Blanc 2 años hace
ACOR One to keep on radar.

mb
👍️0
DK11 DK11 2 años hace
https://www.sec.gov/Archives/edgar/data/1008848/000119312522309544/d368917d8k.htm

They will take care of this soon
👍️0
Orphan Orphan 2 años hace
We spared ACOR, we permitted the reverse stock split because we believe in ACOR and they will do the right things
Your welcome from the wall streets bets Crew
👍️0
Orphan Orphan 2 años hace
They adjurned our meeting for today, ACOR the reverse stock split proposal is going to be voted no so let's not prolong your fate, wich is offer the shareholders a buy back or better or prepare to file your bankruptcy!!!!!!!!!

Most votes are in and it's no go for the reverse stock split !!!!!

Hear from you on November 11th for the meeting
👍️0
Orphan Orphan 2 años hace
Us retail shareholders own the largest portion of this stock , therefore if everyone votes we all know that the reverse split will be a no go!!!!!!, So I as an amc ape / wall streets bets Crew member am putting ACOR on notice prepare to file your bankruptcy or provide us all with a buyback or better.
I'm sure many can agree with me on this
👍️0
cash4 cash4 2 años hace
My friend owns 7 Townhouses in Valley Cottage, I know Rockland very well, I live in The Bronx.
👍️0
everton44 everton44 2 años hace
the company used to be right next door to my building, we use the same parking lot but they cut employees and moved a few months ago. The company used to be well maintained but hands on i saw that the let go of their staff and left westchester county in ny which is one of the most expensive county in the country to rockland county to save money as they were/are dying. they are trying to stay a float but did major cost cutting.
👍️0
cash4 cash4 2 años hace
I hope everyone votes against the R/S as I will, if I go bankrupt so should They, ...the reason they did not want to pay their debts is because bankruptcy will protect them from debts, therefore those they owe money to should exercise a hostile takeover and fire these clowns all together.

As of now the Market Cap dropped to 17 mil, if they want the stock above $1 they should announce a Buyback, they just got $16 mil in their bank the other day, always on the backs of lenders and shareholders, I'm so pissed with these crooks.

The same story with fly-by-night corporations, the losses are public but the profits are private, FOH,...they never share profits, only deficit.

Give me $16 mil and by the end of the trading day I would fire all of them on Zoom.
👍️0
cash4 cash4 2 años hace
This company is run by a bunch of clowns. You announce a Reverse Split proposal when you break $1 in just one day of trading from 34 cents, then you blackmail the shareholders to approve in voting if not you have to declare bankruptcy, when the company got more money awarded than the entire Market Cap is worth ? Bunch of assholes.

I wish some smart wale just buys up the entire free trading float and leaves them with just the 26% owned by the insiders to take this company to the next level.

24 mil shares float, what is the ratio going to be ? They want this stock to have only 2 Mil float ? Are they that stupid, 1st they announce they won't pay debts with shares to protect the shareholders from dilution and how's a Reverse Split going to protect us, morons.
👍️0
everton44 everton44 2 años hace
ACOR doing a reverse split soon, you heard it here first.
👍️0
BoilerRoom BoilerRoom 2 años hace
$RMED yes! Going be a good one imo
👍️0
Upgrader Upgrader 2 años hace
New out , no offering or dillution
👍️0
BoilerRoom BoilerRoom 2 años hace
Hope this turns back up today
👍️0
Invest-in-America Invest-in-America 2 años hace
ACOR: Simply follow BARCHART (free, see link below); & FIDELITY has an excellent (free) daily list of the top running stocks, which they call "MARKET MOVERS". However, in order to SEE Fidelity's important list, you have to OPEN an account with them --- but NO DEPOSIT MONEY is required (ever),
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
Invest-in-America Invest-in-America 2 años hace
ACOR: "Is this good?" Peeps love anything to do with LAWSUITS, bankruptcies, fraud investigations, etc., about ANY company. And, since evidently ACOR just WON a civil action of some nature, well, to the MOON --- at least for THIS particular day. (At this writing, ACOR is DOWN by 8.25% 'after hours', which is no big deal, per se.)

In any event, ACOR closed this day near the TOP of the following (very influential) LIST --- which everyone should follow every day. (Toss-away your silly 'Scanners'; stop 'following' mutha-duckas; & simply let BARCHART make you some bucks!!)
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
subslover subslover 2 años hace
They are looking for NASDAQ compliance and I feel that they will get it. :)
👍️0
BoilerRoom BoilerRoom 2 años hace
$ACOR I’m all in here I need this to pop
👍️0
crudeoil24 crudeoil24 2 años hace
52 week high is 4.83 > The Multi-million dollars award putting ACOR on fast track to new 52 week highs.
👍️0
crudeoil24 crudeoil24 2 años hace
ACOR is a great $$$$$ opportunity.
👍️0
crudeoil24 crudeoil24 2 años hace
"This award will allow Acorda to obtain more competitive market rates for the supply of AMPYRA, significantly reducing our cost of goods and meaningfully increasing the product's value to the company," said Ron Cohen, M.D., Acorda's President and CEO. "This will also help Acorda to continue to provide its customary high level of support for Ampyra, ensuring that as many people with MS as possible may benefit from it."
👍️0
crudeoil24 crudeoil24 2 años hace
Acorda generating $938,000. revenue per employee this past year. Solid news today!
Plenty of upside ahead in upcoming sessions.
👍️0
subslover subslover 2 años hace
A Godzilla move today. Mothra shows up next!
👍️0
Actualfactual Actualfactual 2 años hace
Yeah….the poor guy who shorted it there…
👍️0
tedgoeseast tedgoeseast 2 años hace
Wow poor guy who bought 54,000 @ 1.04 down 20 percent already to .83, I can believe someone would buy when it is up over 170 percent ,will wait for about .75 dip tomorrow or lower I do think it will make it back up over .90
👍️0
BoilerRoom BoilerRoom 2 años hace
$ACOR $2.00 tomorrow
👍️0
BoilerRoom BoilerRoom 2 años hace
$ACOR all in here I think another 100% pop tomorrow
👍️0
BoilerRoom BoilerRoom 2 años hace
$ACOR I agree
👍️0
crudeoil24 crudeoil24 2 años hace
Should surpass 2.00+ by Wednesday. Day traders slowing down momo. Certainly great fundamental news putting ACOR on a higher revenue track.
👍️0

Su Consulta Reciente

NASDAQ
ACOR
Acorda Therapeutics
TG
7BC
Ordinary
BIT
LUSE5
Solactive X5 Daily
TSX
GXE
Gear Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados